Bromide

Bromide

SCHEMBL2495449

Br.N[C@@H]1CCN(Cc2ccccc2)C1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 9/20 0.56
SIGMAR1 known ✓ Q99720 2/20 0.53
BCHE P06276 8/20 0.55
BACE1 P56817 8/20 0.55
LTA4H P09960 1/20 0.55
CCR3 P51677 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54
ALDH1A1 P00352 1/20 0.54
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
DRD3 P35462 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2899465 1.00 ACHE (0.56) ACHEBCHEBACE1LTA4HCCR3
SCHEMBL42501 0.98 ACHE (0.58) ACHEBCHEBACE1LTA4HCCR3
SCHEMBL14793661 0.98 ACHE (0.58) ACHEBCHEBACE1LTA4HCCR3
SCHEMBL330609 0.98 ACHE (0.58) ACHEBCHEBACE1LTA4HCCR3
SCHEMBL239922 0.98 ACHE (0.58) ACHEBCHEBACE1LTA4HCCR3
Hydrochloric Acid SCHEMBL20183286 0.96 ACHE (0.56) ACHEBCHEBACE1LTA4HCCR3
Hydrochloric Acid SCHEMBL2905438 0.96 ACHE (0.56) ACHEBCHEBACE1LTA4HCCR3
Hydrochloric Acid SCHEMBL697482 0.96 ACHE (0.56) ACHEBCHEBACE1LTA4HCCR3
Acetic Acid SCHEMBL2500600 0.89 ACHE (0.53) ACHELTA4HALDH1A1SIGMAR1DRD2
Acetic Acid SCHEMBL2904677 0.89 ACHE (0.53) ACHELTA4HALDH1A1SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030501-B2 Process for producing optically active 3-amino nitrogen-containing compounds KANEKA CORPORATION (JP) 2011-10-04 US disclosed
US-20090326246-A1 Method for Production of Optically Active 3-Amino-Nitrogenated Compound KANEKA CORPORATION (JP) 2009-12-31 US disclosed
EP-2050735-A1 METHOD FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-NITROGENATED COMPOUND Kaneka Corporation (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326246-A1 Method for Production of Optically Active 3-Amino-Nitrogenated Compound PNMT, NPEPPS, GNMT ACHE 66/4885SIGMAR1 625/4885BCHE 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.